{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T17:31:28Z","timestamp":1790703088772,"version":"4.1.0"},"reference-count":81,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.ejmech.2016.09.085","type":"journal-article","created":{"date-parts":[[2016,9,29]],"date-time":"2016-09-29T06:15:14Z","timestamp":1475129714000},"page":"640-651","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":68,"special_numbering":"C","title":["Dihydroorotate dehydrogenase: A drug target for the development of antimalarials"],"prefix":"10.1016","volume":"125","author":[{"given":"Anju","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mudasir","family":"Maqbool","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Mobashir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nasimul","family":"Hoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2016.09.085_bib1","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0140-6736(12)60034-8","article-title":"Global malaria mortality between 1980 and 2010: a systematic analysis","volume":"379","author":"Murray","year":"2012","journal-title":"Lancet (Lond., Engl."},{"key":"10.1016\/j.ejmech.2016.09.085_bib2","series-title":"Introduction to Parasitology: with Special Reference to the Parasites of Man","author":"Chandler","year":"1961"},{"key":"10.1016\/j.ejmech.2016.09.085_bib3","series-title":"Introduction to Animal Parasitology","author":"Smyth","year":"1976"},{"key":"10.1016\/j.ejmech.2016.09.085_bib4","unstructured":"WHO. World Malaria Report. http:\/\/wwwwhoint\/malaria\/media\/world-malaria-report- 2015\/en\/2015. (access date: June 20, 2016)."},{"key":"10.1016\/j.ejmech.2016.09.085_bib5","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/nm.3073","article-title":"Malaria biology and disease pathogenesis: insights for new treatments","volume":"19","author":"Miller","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejmech.2016.09.085_bib6","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/S0140-6736(13)60024-0","article-title":"Malaria","volume":"383","author":"White","year":"2014","journal-title":"Lancet (Lond., Engl."},{"key":"10.1016\/j.ejmech.2016.09.085_bib7","series-title":"Antimalarial Chemotherapy Mechanisms of Action, Resistance, and New Directions in Drug Discovery","article-title":"The history of antimalarial drugs","author":"Meshnick","year":"2001"},{"key":"10.1016\/j.ejmech.2016.09.085_bib8","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/0006-2952(92)90213-3","article-title":"Site of action of the antimalarial hydroxynaphthoquinone, 2-[trans-4-(4\u2019-chlorophenyl) cyclohexyl]-3-hydroxy-1,4-naphthoquinone (566C80)","volume":"43","author":"Fry","year":"1992","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2016.09.085_bib9","doi-asserted-by":"crossref","first-page":"3961","DOI":"10.1074\/jbc.272.7.3961","article-title":"Atovaquone, a broad spectrum antiparasitic drug, collapses mitochondrial membrane potential in a malarial parasite","volume":"272","author":"Srivastava","year":"1997","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2016.09.085_bib10","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1128\/AAC.43.6.1334","article-title":"A\u00a0mechanism for the synergistic antimalarial action of atovaquone and proguanil","volume":"43","author":"Srivastava","year":"1999","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2016.09.085_bib11","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s13020-019-0228-y","article-title":"Artemisinin: a wonder drug from Chinese natural medicines","volume":"14","author":"Wang","year":"2016","journal-title":"Chin. J. Nat. Med."},{"key":"10.1016\/j.ejmech.2016.09.085_bib12","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1126\/science.3887571","article-title":"Qinghaosu (artemisinin): an antimalarial drug from China","volume":"228","author":"Klayman","year":"1985","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2016.09.085_bib13","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1126\/science.1260867","article-title":"Drug resistance. K13-propeller mutations confer artemisinin resistance in Plasmodium falciparum clinical isolates","volume":"347","author":"Straimer","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2016.09.085_bib14","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/ng.3189","article-title":"Genetic architecture of artemisinin-resistant Plasmodium falciparum","volume":"47","author":"Miotto","year":"2015","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ejmech.2016.09.085_bib15","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/nature14451","article-title":"A\u00a0novel multiple-stage antimalarial agent that inhibits protein synthesis","volume":"522","author":"Baraga\u00f1a","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2016.09.085_bib16","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/nrd4573","article-title":"Malaria medicines: a glass half full?","volume":"14","author":"Wells","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2016.09.085_bib17","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1017\/S0031182013000826","article-title":"Antimalarial drug discovery \u2013 the path towards eradication","volume":"141","author":"Burrows","year":"2014","journal-title":"Parasitology"},{"key":"10.1016\/j.ejmech.2016.09.085_bib18","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(15)60721-8","article-title":"Efficacy and safety of RTS,S\/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial","volume":"386","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.ejmech.2016.09.085_bib19","doi-asserted-by":"crossref","first-page":"27458","DOI":"10.1074\/jbc.M502319200","article-title":"Uncovering the molecular mode of action of the antimalarial drug atovaquone using a bacterial system","volume":"280","author":"Mather","year":"2005","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2016.09.085_bib20","doi-asserted-by":"crossref","first-page":"31","DOI":"10.2174\/138945007779315524","article-title":"Targeting purine and pyrimidine metabolism in human apicomplexan parasites","volume":"8","author":"Hyde","year":"2007","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.ejmech.2016.09.085_bib21","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/nature05572","article-title":"Specific role of mitochondrial electron transport in blood-stage Plasmodium falciparum","volume":"446","author":"Painter","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2016.09.085_bib22","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1550-7408.1970.tb05163.x","article-title":"Incorporation of radioactive precursors into DNA and RNA of Plasmodium knowlesi in\u00a0vitro","volume":"17","author":"Gutteridge","year":"1970","journal-title":"J.\u00a0Protozool."},{"key":"10.1016\/j.ejmech.2016.09.085_bib23","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1038\/nature01097","article-title":"Genome sequence of the human malaria parasite Plasmodium falciparum","volume":"419","author":"Gardner","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2016.09.085_bib24","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0969-2126(00)00077-0","article-title":"Structures of human dihydroorotate dehydrogenase in complex with antiproliferative agents","volume":"8","author":"Liu","year":"2000","journal-title":"Structure"},{"key":"10.1016\/j.ejmech.2016.09.085_bib25","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/0304-4165(79)90131-4","article-title":"Conversion of dihydroorotate to orotate in parasitic protozoa","volume":"582","author":"Gutteridge","year":"1979","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ejmech.2016.09.085_bib26","doi-asserted-by":"crossref","first-page":"16197","DOI":"10.1021\/bi971628y","article-title":"Active site of dihydroorotate dehydrogenase A from Lactococcus lactis investigated by chemical modification and mutagenesis","volume":"36","author":"Bj\u00f6rnberg","year":"1997","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejmech.2016.09.085_bib27","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0969-2126(97)00182-2","article-title":"The crystal structure of the flavin containing enzyme dihydroorotate dehydrogenase A from Lactococcus lactis","volume":"5","author":"Rowland","year":"1997","journal-title":"Structure"},{"key":"10.1016\/j.ejmech.2016.09.085_bib28","doi-asserted-by":"crossref","first-page":"12678","DOI":"10.1074\/jbc.M609893200","article-title":"Detergent-dependent kinetics of truncated Plasmodium falciparum dihydroorotate dehydrogenase","volume":"282","author":"Malmquist","year":"2007","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2016.09.085_bib29","doi-asserted-by":"crossref","first-page":"8966","DOI":"10.1073\/pnas.89.19.8966","article-title":"Divergent evolution of pyrimidine biosynthesis between anaerobic and aerobic yeasts","volume":"89","author":"Nagy","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejmech.2016.09.085_bib30","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1002\/pro.5560050506","article-title":"Purification and characterization of dihydroorotate dehydrogenase a from lactococcus lactis, crystallization and preliminary X-ray diffraction studies of the enzyme","volume":"5","author":"Nielsen","year":"2008","journal-title":"Protein Sci."},{"key":"10.1016\/j.ejmech.2016.09.085_bib31","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1006\/abbi.2000.1823","article-title":"Catalytic properties of dihydroorotate dehydrogenase from Saccharomyces cerevisiae: studies on pH, alternate substrates, and inhibitors","volume":"378","author":"Jordan","year":"2000","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.ejmech.2016.09.085_bib32","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1006\/jmbi.1998.2293","article-title":"Novel organization and sequences of five genes encoding all six enzymes for de novo pyrimidine biosynthesis in Trypanosoma cruzi","volume":"285","author":"Gao","year":"1999","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.ejmech.2016.09.085_bib33","doi-asserted-by":"crossref","first-page":"29359","DOI":"10.1074\/jbc.271.46.29359","article-title":"The B form of dihydroorotate dehydrogenase from Lactococcus lactis consists of two different subunits, encoded by the pyrDb and pyrK genes, and contains FMN, FAD, and [FeS] redox centers","volume":"271","author":"Nielsen","year":"1996","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2016.09.085_bib34","doi-asserted-by":"crossref","first-page":"5005","DOI":"10.1128\/jb.178.16.5005-5012.1996","article-title":"Sequence analysis and identification of the pyrKDbF operon from Lactococcus lactis including a novel gene, pyrK, involved in pyrimidine biosynthesis","volume":"178","author":"Andersen","year":"1996","journal-title":"J.\u00a0Bacteriol."},{"key":"10.1016\/j.ejmech.2016.09.085_bib35","doi-asserted-by":"crossref","first-page":"13129","DOI":"10.1021\/bi990674q","article-title":"Dihydroorotate dehydrogenase B of Enterococcus faecalis. Characterization and insights into chemical mechanism","volume":"38","author":"Marcinkeviciene","year":"1999","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejmech.2016.09.085_bib36","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1006\/abbi.1999.1455","article-title":"Biochemical characterization of the heteromeric Bacillus subtilis dihydroorotate dehydrogenase and its isolated subunits","volume":"371","author":"Kahler","year":"1999","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.ejmech.2016.09.085_bib37","doi-asserted-by":"crossref","unstructured":"I. Lieberman, A. Kornberg, Enzymic synthesis and breakdown of a pyrimidine, orotic acid. I. Dihydro-orotic dehydrogenase, Biochim. Biophys. Acta. (12) (n.d.) 223\u2013234.","DOI":"10.1016\/0006-3002(53)90141-3"},{"key":"10.1016\/j.ejmech.2016.09.085_bib38","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1046\/j.1432-1327.2000.01213.x","article-title":"Requirements for the mitochondrial import and localization of dihydroorotate dehydrogenase","volume":"267","author":"Rawls","year":"2000","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.ejmech.2016.09.085_bib39","doi-asserted-by":"crossref","first-page":"3148","DOI":"10.1021\/jm301848w","article-title":"On dihydroorotate dehydrogenases and their inhibitors and uses","volume":"56","author":"Munier-Lehmann","year":"2013","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2016.09.085_bib40","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1021\/jm800963t","article-title":"Structure-based design, synthesis, and characterization of inhibitors of human and Plasmodium falciparum dihydroorotate dehydrogenases","volume":"52","author":"Davies","year":"2009","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2016.09.085_bib41","doi-asserted-by":"crossref","first-page":"8929","DOI":"10.1021\/bi8003318","article-title":"The structures of human dihydroorotate dehydrogenase with and without inhibitor reveal conformational flexibility in the inhibitor and substrate binding sites","volume":"47","author":"Walse","year":"2008","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejmech.2016.09.085_bib42","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1107\/S0907444905042642","article-title":"Structure of Plasmodium falciparum dihydroorotate dehydrogenase with a bound inhibitor","volume":"62","author":"Hurt","year":"2006","journal-title":"Acta Crystallogr. D. Biol. Crystallogr."},{"key":"10.1016\/j.ejmech.2016.09.085_bib43","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1002\/pro.5560070601","article-title":"The crystal structure of lactococcus lactis dihydroorotate dehydrogenase a complexed with the enzyme reaction product throws light on its enzymatic function","volume":"7","author":"Rowland","year":"1998","journal-title":"Protein Sci."},{"key":"10.1016\/j.ejmech.2016.09.085_bib44","doi-asserted-by":"crossref","first-page":"41827","DOI":"10.1074\/jbc.M206854200","article-title":"Malarial dihydroorotate dehydrogenase. Substrate and inhibitor specificity","volume":"277","author":"Baldwin","year":"2002","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2016.09.085_bib45","doi-asserted-by":"crossref","first-page":"226","DOI":"10.2174\/187152610791163336","article-title":"Plasmodium dihydroorotate dehydrogenase: a promising target for novel anti-malarial chemotherapy","volume":"10","author":"Phillips","year":"2010","journal-title":"Infect. Disord. Drug Targets"},{"key":"10.1016\/j.ejmech.2016.09.085_bib46","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/0006-2952(92)90506-E","article-title":"Antimalarial activity of orotate analogs that inhibit dihydroorotase and dihydroorotate dehydrogenase","volume":"43","author":"Krungkrai","year":"1992","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2016.09.085_bib47","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/0006-2952(95)00255-X","article-title":"Inhibition of dihydroorotate dehydrogenase by the immunosuppressive agent leflunomide","volume":"50","author":"Greene","year":"1995","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2016.09.085_bib48","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1006\/clim.1999.4777","article-title":"Mechanism of action for leflunomide in rheumatoid arthritis","volume":"93","author":"Fox","year":"1999","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.ejmech.2016.09.085_bib49","first-page":"3088","article-title":"Dihydroorotate dehydrogenase is a target for the biological effects of leflunomide","volume":"28","author":"Williamson","year":"1996","journal-title":"Transpl. Proc."},{"key":"10.1016\/j.ejmech.2016.09.085_bib50","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1159\/000053979","article-title":"Inhibition of cytomegalovirus in\u00a0vitro and in\u00a0vivo by the experimental immunosuppressive agent leflunomide","volume":"42","author":"Waldman","year":"1999","journal-title":"Intervirology"},{"key":"10.1016\/j.ejmech.2016.09.085_bib51","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1021\/bi952168g","article-title":"The immunosuppressive metabolite of leflunomide is a potent inhibitor of human dihydroorotate dehydrogenase","volume":"35","author":"Davis","year":"1996","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejmech.2016.09.085_bib52","doi-asserted-by":"crossref","first-page":"21682","DOI":"10.1074\/jbc.273.34.21682","article-title":"Leflunomide inhibits pyrimidine de novo synthesis in mitogen-stimulated T-lymphocytes from healthy humans","volume":"273","author":"R\u00fcckemann","year":"1998","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2016.09.085_bib53","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0009-2797(99)00144-1","article-title":"Kinetics of inhibition of human and rat dihydroorotate dehydrogenase by atovaquone, lawsone derivatives, brequinar sodium and polyporic acid","volume":"124","author":"Knecht","year":"2000","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.ejmech.2016.09.085_bib54","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1110\/ps.03533004","article-title":"Inhibitor binding in a class 2 dihydroorotate dehydrogenase causes variations in the membrane-associated N-terminal domain","volume":"13","author":"Hansen","year":"2004","journal-title":"Protein Sci."},{"key":"10.1016\/j.ejmech.2016.09.085_bib55","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s000110050720","article-title":"Anti-arthritic effects of KF20444, a new immunosuppressive compound inhibiting dihydroorotate dehydrogenase, on rat collagen-induced arthritis","volume":"50","author":"Kobayashi","year":"2001","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.ejmech.2016.09.085_bib56","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0960-894X(98)00010-9","article-title":"Structure-activity relationships (SAR) of some tetracyclic heterocycles related to the immunosuppressive agent Brequinar Sodium","volume":"8","author":"Pitts","year":"1998","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2016.09.085_bib57","series-title":"Dihydroorotate Dehydrogenase Inhibitors as Antiinflammatory Agents, Autoimmune Disease Remedies, Immunosuppressants, Anticancer Drugs, Fungicides, and Virucides","author":"Horigome","year":"2004"},{"key":"10.1016\/j.ejmech.2016.09.085_bib58","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1016\/j.bmc.2005.01.017","article-title":"Synthesis of brequinar analogue inhibitors of malaria parasite dihydroorotate dehydrogenase","volume":"13","author":"Boa","year":"2005","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2016.09.085_bib59","series-title":"Combination Comprising Methotrexate and DHODH Inhibitors","author":"Godessart","year":"2010"},{"key":"10.1016\/j.ejmech.2016.09.085_bib60","series-title":"Amino Derivatives for the Treatment of Proliferative Skin Disorders","author":"Godessart","year":"2012"},{"key":"10.1016\/j.ejmech.2016.09.085_bib61","series-title":"Merikapudi, Preparation of Biphenylcarbamoylbenzoic Acid Derivatives as Dihydroorotate Dehydrogenase Inhibitors","author":"Muthuppalaniappan","year":"2011"},{"key":"10.1016\/j.ejmech.2016.09.085_bib62","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.crohns.2012.09.016","article-title":"Efficacy, safety and tolerability of vidofludimus in patients with inflammatory bowel disease: the ENTRANCE study","volume":"7","author":"Herrlinger","year":"2013","journal-title":"J.\u00a0Crohns. Colitis"},{"key":"10.1016\/j.ejmech.2016.09.085_bib63","series-title":"Preparation of Biphenylylpyridine Derivatives as Dihydroorotate Dehydrogenase Inhibitors","author":"Arimura","year":"2003"},{"key":"10.1016\/j.ejmech.2016.09.085_bib64","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1128\/AAC.00525-07","article-title":"Discovery and characterization of substituted diphenyl heterocyclic compounds as potent and selective inhibitors of hepatitis C virus replication","volume":"52","author":"Huang","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2016.09.085_bib65","doi-asserted-by":"crossref","first-page":"7425","DOI":"10.1021\/jm300351w","article-title":"Bioisosteric transformations and permutations in the triazolopyrimidine scaffold to identify the minimum pharmacophore required for inhibitory activity against Plasmodium falciparum dihydroorotate dehydrogenase","volume":"55","author":"Marwaha","year":"2012","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2016.09.085_bib66","doi-asserted-by":"crossref","first-page":"5381","DOI":"10.1021\/jm500481t","article-title":"Fluorine modulates species selectivity in the triazolopyrimidine class of Plasmodium falciparum dihydroorotate dehydrogenase inhibitors","volume":"57","author":"Deng","year":"2014","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2016.09.085_bib67","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaa6645","article-title":"A\u00a0long-duration dihydroorotate dehydrogenase inhibitor (DSM265) for prevention and treatment of malaria","volume":"7","author":"Phillips","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ejmech.2016.09.085_bib68","doi-asserted-by":"crossref","first-page":"5416","DOI":"10.1021\/acs.jmedchem.6b00275","article-title":"Tetrahydro-2-naphthyl and 2-indanyl triazolopyrimidines targeting Plasmodium falciparum dihydroorotate dehydrogenase display potent and selective antimalarial activity","volume":"59","author":"Kokkonda","year":"2016","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2016.09.085_bib69","doi-asserted-by":"crossref","first-page":"7911","DOI":"10.1021\/jm400938g","article-title":"Novel selective and potent inhibitors of malaria parasite dihydroorotate dehydrogenase: discovery and optimization of dihydrothiophenone derivatives","volume":"56","author":"Xu","year":"2013","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2016.09.085_bib70","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1021\/ml200143c","article-title":"Optimization of potent inhibitors of P. Falciparum dihydroorotate dehydrogenase for the treatment of malaria","volume":"2","author":"Skerlj","year":"2011","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2016.09.085_bib71","first-page":"206","volume":"51","author":"Phillips","year":"2009","journal-title":"NIH Public Access"},{"key":"10.1016\/j.ejmech.2016.09.085_bib72","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1021\/acs.jcim.5b00680","article-title":"Identification of new human malaria parasite Plasmodium falciparum dihydroorotate dehydrogenase inhibitors by pharmacophore and structure-based virtual screening","volume":"56","author":"Pavadai","year":"2016","journal-title":"J.\u00a0Chem. Inf. Model."},{"key":"10.1016\/j.ejmech.2016.09.085_bib73","doi-asserted-by":"crossref","first-page":"33054","DOI":"10.1074\/jbc.M110.162081","article-title":"Novel inhibitors of Plasmodium falciparum dihydroorotate dehydrogenase with anti-malarial activity in the mouse model","volume":"285","author":"Booker","year":"2010","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2016.09.085_bib74","doi-asserted-by":"crossref","first-page":"5579","DOI":"10.1021\/acs.jmedchem.5b00606","article-title":"Original 2-(3-Alkoxy-1 H -pyrazol-1-yl)azines inhibitors of human dihydroorotate dehydrogenase (DHODH)","volume":"58","author":"Lucas-Hourani","year":"2015","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2016.09.085_bib75","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1021\/jm501127s","article-title":"Design, synthesis, X-ray crystallographic analysis, and biological evaluation of thiazole derivatives as potent and selective inhibitors of human dihydroorotate dehydrogenase","volume":"58","author":"Zhu","year":"2015","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2016.09.085_bib76","doi-asserted-by":"crossref","first-page":"3175","DOI":"10.1039\/p19880003175","article-title":"Latent inhibitors. Part 4. Irreversible inhibition of dihydro-orotate dehydrogenase by hydantoins derived from amino acids","volume":"1","author":"Buntain","year":"1988","journal-title":"J.\u00a0Chem. Soc. Perkin Trans."},{"key":"10.1016\/j.ejmech.2016.09.085_bib77","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0006-2952(00)00348-8","article-title":"Selective inhibition of bacterial dihydroorotate dehydrogenases by thiadiazolidinediones","volume":"60","author":"Marcinkeviciene","year":"2000","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2016.09.085_bib78","doi-asserted-by":"crossref","first-page":"33373","DOI":"10.1074\/jbc.M004451200","article-title":"Helicobacter pylori-selective antibacterials based on inhibition of pyrimidine biosynthesis","volume":"275","author":"Copeland","year":"2000","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2016.09.085_bib79","series-title":"Preparation of Pyrimidine Derivatives for Use as Antibiotics, Specifically as Bacterial Dihydroorotate Dehydrogenase (DHODase) Inhibitors","author":"Vernallis","year":"2010"},{"key":"10.1016\/j.ejmech.2016.09.085_bib80","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s002940050115","article-title":"Identification of a new antifungal target site through a dual biochemical and molecular-genetics approach","volume":"30","author":"Gustafson","year":"1996","journal-title":"Curr. Genet."},{"key":"10.1016\/j.ejmech.2016.09.085_bib81","series-title":"Quinazolinone Antifungal Agents Targeting Dihydroorotate Dehydrogenase (DHODH) Protein of a Fungus","author":"Oliver","year":"2009"}],"updated-by":[{"DOI":"10.1016\/j.ejmech.2017.02.023","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2017,3,10]],"date-time":"2017-03-10T00:00:00Z","timestamp":1489104000000}}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523416308212?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523416308212?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T13:43:40Z","timestamp":1759326220000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523416308212"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":81,"alternative-id":["S0223523416308212"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2016.09.085","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.ejmech.2017.02.023","asserted-by":"object"}]},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dihydroorotate dehydrogenase: A drug target for the development of antimalarials","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2016.09.085","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}